Cargando…

Efficacy and Safety of Propiverine in Children with Overactive Bladder

PURPOSE: Antimuscarinic therapy remains one of the most common forms of therapy for overactive bladder (OAB) in children. However, few clinical studies on the outcomes of antimuscarinics in children with OAB have been published. Therefore, we evaluated the efficacy and safety of propiverine, which i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Woo Jung, Lee, Dong-Gi, Lee, Sang Wook, Lee, Yoon Kyung, Lee, Jae Seung, Park, Kwan Hyun, Baek, Minki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332140/ https://www.ncbi.nlm.nih.gov/pubmed/22536472 http://dx.doi.org/10.4111/kju.2012.53.4.275

Ejemplares similares

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany
por: Murgas, Sandra, et al.
Publicado: (2019)

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation
por: Oh, Jun Hyung, et al.
Publicado: (2010)

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine
por: Müderrisoglu, A. Elif, et al.
Publicado: (2022)

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2014)

Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2015)

Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting
por: Amiri, Marjan, et al.
Publicado: (2021)

Efficacy and Safety of Low-Dose Propiverine in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia with Storage Symptoms: A Prospective, Randomized, Single-Blinded and Multicenter Clinical Trial
por: Bae, Jae Hyun, et al.
Publicado: (2011)

Efficacy, Tolerability, and Safety of Oxybutynin Chloride in Pediatric Neurogenic Bladder With Spinal Dysraphism: A Retrospective, Multicenter, Observational Study
por: Lee, Jung Hoon, et al.
Publicado: (2014)

Propiverine Hydrochloride as a Treatment for Fecal Incontinence
por: Irei, Yasue, et al.
Publicado: (2020)

Time Course of Treatment for Primary Enuresis With Overactive Bladder
por: Im, Young Jae, et al.
Publicado: (2018)

Prevalence and Treatment Efficacy of Genitourinary Mycoplasmas in Women with Overactive Bladder Symptoms
por: Lee, Young-Suk, et al.
Publicado: (2010)

The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder
por: Kim, Ji Hyun, et al.
Publicado: (2011)

Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder: A prospective, randomized controlled, crossover-design, pilot study
por: Lee, Hye-Yoon, et al.
Publicado: (2018)

Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study
por: Shim, Myungsun, et al.
Publicado: (2020)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022)

Seasonal Variation of Overactive Bladder Symptoms in Female Patients
por: Tae, Bum Sik, et al.
Publicado: (2019)

Efficacy and tolerability of mirabegron compared with solifenacin for children with idiopathic overactive bladder: A preliminary study
por: Kim, Seong Cheol, et al.
Publicado: (2021)

Urothelial Tumors of the Urinary Bladder in Two Adolescent Patients: Emphasis on Follow-up Methods
por: Park, Sungchan, et al.
Publicado: (2014)

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study
por: Choo, M-S, et al.
Publicado: (2008)

Significance of an endoscopically injected nodule detected on ultrasound as a predictive factor for the resolution of vesicoureteral reflux
por: LEE, DONG-GI, et al.
Publicado: (2015)

Risk factors for contralateral patent processus vaginalis determined by transinguinal laparoscopic examination
por: LEE, DONG-GI, et al.
Publicado: (2015)

Efficacy and Safety of Hexaminolevulinate Fluorescence Cystoscopy in the Diagnosis of Bladder Cancer
por: Lee, Jae Seung, et al.
Publicado: (2012)

Efficacy and safety of low-dose anticholinergics to treat men with lower urinary tract symptoms with overactive bladder: a retrospective study based on real life practice
por: Park, Kyung Kgi, et al.
Publicado: (2013)

Korean Translation and Linguistic Validation of Urgency and Overactive Bladder Questionnaires
por: Kim, Seung-Ee, et al.
Publicado: (2020)

The Urologist's View of Male Overactive Bladder: Discrepancy between Reality and Belief in Practical Setting
por: Lee, Seung Hwan, et al.
Publicado: (2010)

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment
por: Kim, Aram, et al.
Publicado: (2017)

A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
por: Shin, Jung Hyun, et al.
Publicado: (2023)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Ulahannan, Danny, et al.
Publicado: (2009)

Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
por: Makhani, Asad, et al.
Publicado: (2020)

Efficacy of tolterodine in children with overactive bladder
por: Koç, Başak, et al.
Publicado: (2020)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
por: Shim, Ji Sung, et al.
Publicado: (2016)

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
por: Choi, Hoon, et al.
Publicado: (2018)

Near-Normalized Gene Expression Profiles in Bladder With Detrusor Overactivity in Rats With Bladder Outlet Obstruction After Deobstruction
por: Lee, Tack, et al.
Publicado: (2017)

Socioeconomic Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
por: Sung, Wooseuk, et al.
Publicado: (2012)

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
por: Xu, Yankai, et al.
Publicado: (2017)

Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder
por: Lee, Seung Hwan, et al.
Publicado: (2014)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

A Predictive Factor in Overactive Bladder Symptoms Improvement after Combined Anterior Vaginal Wall Prolapse Repair: A Pilot Study
por: Lee, Dong Min, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4dknavsca9jbnh4plutucajvhv